Reuters logo
Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln
November 15, 2017 / 3:37 AM / a month ago

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

Nov 15 (Reuters) - State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc’s China business, one of the nation’s largest drug distributors, for $557 million.

The deal, which includes shareholder loans, gives the China unit an enterprise value of $1.2 billion. (Reporting by Julie Zhu; Editing by Edwina Gibbs)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below